Rainbow Coral Corp.

As part of the company’s push to carve out a share of the $142 billion U.S. drug delivery market, Rainbow Coral Corp. (OTCBB: RBCC) opened talks this week ... read more

Rainbow Coral Corp. (OTCBB: RBCC) received word this week that the revolutionary technology developed by its partner, Nano3D Biosciences (n3D), is set to begin penetrating the U.S. marketplace. ... read more

Nature, the world’s premiere science journal, has finally caught on to what Rainbow Coral Corp. (OTCBB: RBCC) has known for some time: The cell-growth technology pioneered by RBCC ... read more

With the surging trend of personalized genomic medicine poised to radically change not only the way that pharmaceutical companies develop drugs, but the way insurance companies administer healthcare ... read more

In a bid to expand the market for its biotech innovations beyond North America, Rainbow Coral Corp. (OTCBB: RBCC) is seeking out new overseas targets that stand to ... read more

Rainbow BioSciences, the biotech division of Rainbow Coral Corp. (OTCBB: RBCC), today announced that it is wrapping up negotiations toward a definitive agreement with a leading, Texas-based genetic ... read more

As Rainbow Coral Corp.’s (OTCBB: RBCC) biotech subsidiary, Rainbow BioSciences, seeks out potentially lucrative new opportunities in the $232 billion personalized medicine market, the company announced today ... read more

Last week, Rainbow BioSciences, the biotechnology division of Rainbow Coral Corp. (OTCBB: RBCC), unveiled a new website highlighting its explorations into the multi-billion-dollar drug delivery and ... read more

Only days after signing a joint venture agreement with cutting-edge drug delivery innovators TheraKine, Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp. (OTCBB: RBCC) is working hard ... read more

As part of a bold expansion into the $60 billion global drug delivery market, Rainbow BioSciences, the biotech division of Rainbow Coral Corp. (OTCBB: RBCC), today announced it ... read more

The next generation of advanced pharmaceutical technologies could be poised to fuel remarkable growth in the $60 billion global drug delivery market, and Rainbow Biosciences—the biotech subsidiary of ... read more

Rainbow Coral Corp. (OTCBB: RBCC), a biotech company focused on delivering new medical technologies and innovations, today reports its anticipation of partnering with a cutting-edge genome-mapping facility ... read more

Rainbow Coral Corp. (OTCBB: RBCC) biotech division Rainbow BioSciences is currently in talks to help develop and market a revolutionary, sustained-release drug delivery platform that could soon make ... read more

Rainbow Coral Corp. (OTCBB: RBCC) is kicking-off a new investor outreach campaign by hiring an up-and-coming, dynamic investor relations group committed to enhancing the visibility and reach of ... read more

The magnetic levitation technology that Rainbow Coral Corp. (OTCBB: RBCC) joint venture partner Nano3D BioSciences (n3D) recently used to grow lifelike human lung tissue could one day lead ... read more

New research indicates that 3-D cell culturing technology developed by Rainbow Coral Corp. (OTCBB: RBCC) partner Nano 3D BioSciences (n3D) could make toxicity tests for airborne chemicals faster ... read more

Since the new year began, Rainbow Coral Corp. (OTCBB: RBCC) has wasted no time in searching for new targets to add to its portfolio of projects for commercialization. ... read more

Rainbow Coral Corp. (OTCBB: RBCC) leadership is in San Francisco this week to scout exciting new biotech partnership opportunities at Biotech Showcase ™ 2013. ... read more

Rainbow Coral Corp.’s (OTCBB: RBCC) pending joint venture partner Amarantus BioScience, Inc. (OTCBB: AMBS) announced last week that it has licensed a highly promising new diagnostic known as ... read more

Rainbow Coral Corp. (OTCBB: RBCC) joint venture target Amarantus Bioscience, Inc. (OTCQB: AMBS) recently won a major victory when its patent for MANF, the company’s proprietary anti-apoptosis therapeutic ... read more